Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
BioHarvest Sciences ( (BHST) ) just unveiled an announcement.
On October 30, 2025, BioHarvest Sciences announced a strategic partnership with Saffron Tech to develop and commercialize saffron-derived botanical compounds using BioHarvest’s Botanical Synthesis platform. This collaboration aims to revolutionize saffron production by enabling consistent, scalable, and cost-effective production, addressing the challenges of traditional saffron cultivation. The partnership will allow BioHarvest to leverage its technology for large-scale manufacturing and marketing of saffron-based nutraceutical products. Additionally, BioHarvest shared its preliminary third-quarter 2025 results, with expected revenue of approximately $9.1 million and provided guidance for the fourth quarter, highlighting growth in its VINIA® business and CDMO services.
The most recent analyst rating on (BHST) stock is a Hold with a $10.00 price target. To see the full list of analyst forecasts on BioHarvest Sciences stock, see the BHST Stock Forecast page.
Spark’s Take on BHST Stock
According to Spark, TipRanks’ AI Analyst, BHST is a Neutral.
BioHarvest Sciences faces significant financial challenges, with high leverage and negative equity impacting its long-term sustainability. While technical indicators show some positive momentum, the valuation remains unattractive due to ongoing losses. The earnings call provided a positive outlook with strong revenue growth and strategic initiatives, but increased expenses and net losses remain concerns.
To see Spark’s full report on BHST stock, click here.
More about BioHarvest Sciences
BioHarvest Sciences Inc. is a biotechnology company that specializes in Botanical Synthesis, a patented technology platform that allows for the production of plant-based compounds without growing the plant itself. The company operates in two main business verticals: as a contract development and manufacturing organization (CDMO) for novel plant-based compounds and as a creator of proprietary nutraceutical health and wellness products, including dietary supplements.
Average Trading Volume: 59,732
Technical Sentiment Signal: Buy
Current Market Cap: $191.2M
For an in-depth examination of BHST stock, go to TipRanks’ Overview page.